Subscribe FREE for daily biohub news covering the Boston, San Diego, San Francisco, Philadelphia, Los Angeles, New York City, Capital Region, and Seattle areas.
San Francisco, CA
Joined December 2013
- Tweets16.7K
- Following2.4K
- Followers3.2K
- Likes10.9K
Pinned Tweet
Top 10 U.S. Biopharma Clusters 2026 genengnews.com/topics/drug-d… via @GENbio #Big4Bio #biotech #lifesciences
This week's CEO Weekly Q&A: Robin Toft, CEO of @Curebound. A 20-year colon cancer survivor who went from patient to executive search founder to leading a $51.5M #cancerresearch accelerator in San Diego. Her story is unlike anything else in biotech leadership.
Read it: big4bio.com/resources/spotli…
On this week’s episode of “The Readout LOUD,” @statnews chats with longtime #biotech executive Jeremy Levin about his new book, “Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust.”
That sounds alarmist, and it is in some respects, but as Levin explains, the book is also a roadmap to a brighter future for the biotech industry.
megaphone.link/TTSAA73703030…
Big4Bio retweeted
Katia Riddle at @NPR went inside our Boston facility to witness Nebula, the world’s largest autonomous lab, in action. She spoke with our co-founders @jrkelly and @reshmapshetty about how autonomous labs are already shaping the future of scientific discovery.
🎧 Listen to the episode on All Things Considered: hubs.la/Q04j1MSQ0
How to maximize cancer drug candidate potential through molecular radiotherapy
Explore the program framework, logistics, and critical research components for building IND-ready radiotherapies.
bit.ly/4wO6upi
#cancer #Radiopharmaceuticals #OncologyResearch #webinar
BIG4BIO WEEKLY CEO Q&A:
Maher Masoud, President & CEO, MaxCyte®
In this Q&A, Masoud reflects on what drew him to lead @MaxCyte_info, how its Flow Electroporation® platform and SeQure™ gene editing characterization services are enabling the next generation of cell therapies, and why the company positions itself not as a vendor but as an embedded partner in its customers’ success
big4bio.com/resources/spotli…
#geneediting #sicklecelldisease
US taps small San Diego #biotech for experimental #Ebola treatment as epidemic worsens fiercebiotech.com/biotech/us…
Big4Bio retweeted
Artificial intelligence is rapidly accelerating scientific output, but risks narrowing inquiry, weakening judgement and undermining how scientists are trained
go.nature.com/4nzxBAc
Big4Bio retweeted
Our Founder & CEO, @Connor_G_Glass, was featured in this week’s @big4bio LifeSci Startup CEO Q&A. He discussed Phantom X, our minimally invasive muscle-machine interface, and the importance of scalable #neurotech for patients.
🔗 Read more here: bit.ly/4wEFLLK
Online Auction May 19-21, 2026
BioMarin West Coast Lab Restructure – California Multi-Site Event
Featuring Advanced Analytical, Sequencing & Processing Systems Across California—Highlighted by Illumina NovaSeq 6000, Sciex Zeno TOF 7600, and Complete Bioprocessing Solutions. San Rafael Assets Must Be Removed by June 16th—Plan Accordingly.
bit.ly/4dtjTdv
Introducing The #Big4Bio CEO Weekly Q&A
Every Monday, we spotlight a life sciences CEO from one of our 8 coverage regions — their story, their science, their vision.
First feature is live now: Q&A with Sean McCarthy, CEO of @CytomXInc -- big4bio.com/resources/spotli…
CEOs & comms agencies: [email protected] to get featured. #lifesciences #biotech #CEO
MBC BioLabs bets on #AI boom to boost #biotech startups - San Francisco Business Times
bizjournals.com/sanfrancisco… via @SFBusinessTimes
#startups #lifesciences
Big4Bio retweeted
Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
statnews.com/2026/05/14/rege… via @statnews
Big4Bio retweeted
Join 400+ thought leaders and influencers from industry and academia who will convene at #NGDx in Washington, D.C. on August 24-26 to discuss #diagnostic advancement and technology innovation. Early-bird savings deadline extended until this Friday, May 15. tinyurl.com/y9a538ky
Odyssey voyages to #Nasdaq with $304M #IPO to fund autoimmune, inflammatory pipeline
fiercebiotech.com/biotech/od…
Big4Bio retweeted
Obituary: J Craig Venter (1946-2026) maverick biotechnologist who sequenced the human genome
go.nature.com/4dussWD
Big4Bio retweeted
"The human genome encodes for a new category of molecule"
"The ‘dark proteome’ is upending our understanding of human disease"
@Nature
"Expanding the human proteome with microproteins and peptideins"
nature.com/articles/s41586-0…
statnews.com/2026/05/06/dark… @statnews @MeganMolteni
economist.com/science-and-te… @TheEconomist
Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics
“We believe Anagram is well positioned to transform the treatment of pancreatic insufficiency, especially in patients of all ages who suffer from cystic fibrosis,” said Dr. Nicholas Galakatos, Global Head of Blackstone Life Sciences. “This is an excellent case study of our ownership strategy where we bring scale capital, deep domain expertise, and hands-on engagement to help address large unmet medical needs.”
blackstone.com/news/press/bl…
@anagramtx @blackstone #biotech #CF $BX
